The Global Biosimulation Market size was estimated at USD 2,461.84 million in 2021 and expected to reach USD 2,874.69 million in 2022, and is projected to grow at a CAGR 16.94% to reach USD 6,297.89 million by 2027.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biosimulation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product & Service, the market was studied across Services and Software. The Services is further studied across Contract Services and In-house Services. The Software is further studied across Molecular Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Pk/Pd Modeling and Simulation Software, Toxicity Prediction Software, and Trial Design Software.
Based on Delivery Model, the market was studied across Ownership Models and Subscription Models.
Based on End-user, the market was studied across Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Regulatory Authorities, and Research Institutes.
Based on Application, the market was studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing. The Preclinical Testing is further studied across Adme/Tox and Pk/Pd. The Drug Discovery is further studied across Lead Identification and Optimization and Target Identification and Validation.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.
This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biosimulation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biosimulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biosimulation Market, including Advanced Chemistry Development, Certara, Chemical Computing Group ULC, Dassault Systèmes, Evidera, Gendata AG, In silico biosciences, INOSIM Software, Insilico Biotechnology AG, LeadInvent Pharma Inc, Nuventra Pharma Sciences, Physiomics Plc, Rosa & Co. LLC., Schrödinger, Inc., and Simulations Plus.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biosimulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biosimulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biosimulation Market?
4. What is the competitive strategic window for opportunities in the Global Biosimulation Market?
5. What are the technology trends and regulatory frameworks in the Global Biosimulation Market?
6. What is the market share of the leading vendors in the Global Biosimulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Biosimulation Market?
Please Note: PDF & Excel + Online Access - 1 Year
Companies Mentioned
Advanced Chemistry Development
Certara
Chemical Computing Group ULC
Dassault Systèmes
Evidera
Gendata AG
In silico biosciences
INOSIM Software
Insilico Biotechnology AG
LeadInvent Pharma Inc
Nuventra Pharma Sciences
Physiomics Plc
Rosa & Co. LLC.
Schrödinger, Inc.
Simulations Plus
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Potential demand attributed to adaptations of biosimulation in various sectors such as biotechnology
- 5.1.1.2. Growing demand associated with application of biosimulation in clinical trials
- 5.1.1.3. Rising investments in drug developments and drug testings
- 5.1.2. Restraints
- 5.1.2.1. Upscaled prices involved in installations and technique developments for biosimulation
- 5.1.3. Opportunities
- 5.1.3.1. Favorable governmental laws and regulations to implement biosimulation
- 5.1.3.2. Increasing investments in research and development for utilization of biosimulation
- 5.1.4. Challenges
- 5.1.4.1. Lack of awareness coupled with scarcity of professionals for research and development
- 5.2. Cumulative Impact of COVID-19
- 5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
- 6. Biosimulation Market, by Product & Service
- 6.1. Introduction
- 6.2. Services
- 6.2.1. Contract Services
- 6.2.2. In-house Services
- 6.3. Software
- 6.3.1. Molecular Modeling and Simulation Software
- 6.3.2. Pbpk Modeling and Simulation Software
- 6.3.3. Pk/Pd Modeling and Simulation Software
- 6.3.4. Toxicity Prediction Software
- 6.3.5. Trial Design Software
- 7. Biosimulation Market, by Delivery Model
- 7.1. Introduction
- 7.2. Ownership Models
- 7.3. Subscription Models
- 8. Biosimulation Market, by End-user
- 8.1. Introduction
- 8.2. Contract Research Organizations
- 8.3. Pharmaceutical And Biotechnology Companies
- 8.4. Regulatory Authorities
- 8.5. Research Institutes
- 9. Biosimulation Market, by Application
- 9.1. Introduction
- 9.2. Drug Development
- 9.2.1. Clinical Trials
- 9.2.2. Preclinical Testing
- 9.2.2.1. Adme/Tox
- 9.2.2.2. Pk/Pd
- 9.3. Drug Discovery
- 9.3.1. Lead Identification and Optimization
- 9.3.2. Target Identification and Validation
- 10. Americas Biosimulation Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Biosimulation Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 12. Europe, Middle East & Africa Biosimulation Market
- 12.1. Introduction
- 12.2. France
- 12.3. Germany
- 12.4. Italy
- 12.5. Netherlands
- 12.6. Qatar
- 12.7. Russia
- 12.8. Saudi Arabia
- 12.9. South Africa
- 12.10. Spain
- 12.11. United Arab Emirates
- 12.12. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.1.1. Quadrants
- 13.1.2. Business Strategy
- 13.1.3. Product Satisfaction
- 13.2. Market Ranking Analysis
- 13.3. Market Share Analysis, By Key Player
- 13.4. Competitive Scenario
- 13.4.1. Merger & Acquisition
- 13.4.2. Agreement, Collaboration, & Partnership
- 13.4.3. New Product Launch & Enhancement
- 13.4.4. Investment & Funding
- 13.4.5. Award, Recognition, & Expansion
- 14. Company Usability Profiles
- 14.1. Advanced Chemistry Development
- 14.2. Certara
- 14.3. Chemical Computing Group ULC
- 14.4. Dassault Systèmes
- 14.5. Evidera
- 14.6. Gendata AG
- 14.7. In silico biosciences
- 14.8. INOSIM Software
- 14.9. Insilico Biotechnology AG
- 14.10. LeadInvent Pharma Inc
- 14.11. Nuventra Pharma Sciences
- 14.12. Physiomics Plc
- 14.13. Rosa & Co. LLC.
- 14.14. Schrödinger, Inc.
- 14.15. Simulations Plus
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook